Chromatin remodeling complex in Treg function

International Immunopharmacology

Volumn 9, Issue 5, 2009, Pages 521-523

  Jani, Anant ^a   Chi, Tian ^a   Wan, Yisong Y ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Chromatin; Treg

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; TRANSCRIPTION FACTOR FOXP3; DNA HELICASE; NUCLEAR PROTEIN; SMARCA2 PROTEIN, MOUSE; SMARCA4 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BRG GENE; CHROMATIN ASSEMBLY AND DISASSEMBLY; EFFECTOR CELL; GENE; GENE DELETION; GENE EXPRESSION REGULATION; HOMEOSTASIS; IMMUNOLOGICAL TOLERANCE; KNOCKOUT MOUSE; LETHALITY; LYMPHOID ORGAN; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; THYMUS; ANIMAL; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; ULTRASTRUCTURE;

ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA HELICASES; HUMANS; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS; SELF TOLERANCE; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION FACTORS;

EID: 63549116372     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.01.019     Document Type: Article

References (46)

1. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
2. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531-562
3. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6 (2005) 345-352
4. Shevach E.M. Regulatory T cells in autoimmmunity*. Annu Rev Immunol 18 (2000) 423-449
5. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2 (2002) 389-400
6. Green E.A., Gorelik L., McGregor C.M., Tran E.H., and Flavell R.A. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc Natl Acad Sci U S A 100 (2003) 10878-10883
7. Nakamura K., Kitani A., and Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194 (2001) 629-644
8. Dieckmann D., Plottner H., Berchtold S., Berger T., and Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 193 (2001) 1303-1310
9. Papiernik M., do Carmo Leite-de-Moraes M., Pontoux C., Joret A.M., Rocha B., Penit C., et al. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity. J Immunol 158 (1997) 4642-4653
10. Stephens L.A., Mottet C., Mason D., and Powrie F. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 31 (2001) 1247-1254
11. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27 (2001) 20-21
12. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27 (2001) 68-73
13. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 (2003) 330-336
14. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
15. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27 (2001) 18-20
16. Khattri R., Kasprowicz D., Cox T., Mortrud M., Appleby M.W., Brunkow M.E., et al. The amount of scurfin protein determines peripheral T cell number and responsiveness. J Immunol 167 (2001) 6312-6320
17. Kasprowicz D.J., Smallwood P.S., Tyznik A.J., and Ziegler S.F. Scurfin (FoxP3) controls T-dependent immune responses in vivo through regulation of CD4+ T cell effector function. J Immunol 171 (2003) 1216-1223
18. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., and Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005) 329-341
19. Wan Y.Y., and Flavell R.A. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci U S A 102 (2005) 5126-5131
20. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
21. Powrie F., Read S., Mottet C., Uhlig H., and Maloy K. Control of immune pathology by regulatory T cells. Novartis Found Symp 252 (2003) 92-98 discussion 98-105, 106-14
22. Fontenot J.D., Rasmussen J.P., Gavin M.A., and Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6 (2005) 1142-1151
23. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445 (2007) 771-775
24. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.K., and Flavell R.A. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24 (2006) 99-146
25. Khavari P.A., Peterson C.L., Tamkun J.W., Mendel D.B., and Crabtree G.R. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 366 (1993) 170-174
26. Muchardt C., and Yaniv M. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. Embo J 12 (1993) 4279-4290
27. Wang W., Cote J., Xue Y., Zhou S., Khavari P.A., Biggar S.R., et al. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. Embo J 15 (1996) 5370-5382
28. Bultman S., Gebuhr T., Yee D., La Mantia C., Nicholson J., Gilliam A., et al. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell 6 (2000) 1287-1295
29. Chi T.H., Wan M., Lee P.P., Akashi K., Metzger D., Chambon P., et al. Sequential roles of Brg, the ATPase subunit of BAF chromatin remodeling complexes, in thymocyte development. Immunity 19 (2003) 169-182
30. Strobeck M.W., Reisman D.N., Gunawardena R.W., Betz B.L., Angus S.P., Knudsen K.E., et al. Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling. J Biol Chem 277 (2002) 4782-4789
31. Reyes J.C., Barra J., Muchardt C., Camus A., Babinet C., and Yaniv M. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). Embo J 17 (1998) 6979-6991
32. Gebuhr T.C., Kovalev G.I., Bultman S., Godfrey V., Su L., and Magnuson T. The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J Exp Med 198 (2003) 1937-1949
33. Narlikar G.J., Fan H.Y., and Kingston R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell 108 (2002) 475-487
34. Xu W., Cho H., Kadam S., Banayo E.M., Anderson S., Yates III J.R., et al. A methylation-mediator complex in hormone signaling. Genes Dev 18 (2004) 144-156
35. Tong J.K., Hassig C.A., Schnitzler G.R., Kingston R.E., and Schreiber S.L. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 395 (1998) 917-921
36. Xue Y., Wong J., Moreno G.T., Young M.K., Cote J., and Wang W. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell 2 (1998) 851-861
37. Zhang Y., LeRoy G., Seelig H.P., Lane W.S., and Reinberg D. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 95 (1998) 279-289
38. Chi T.H., Wan M., Zhao K., Taniuchi I., Chen L., Littman D.R., et al. Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. Nature 418 (2002) 195-199
39. Morshead K.B., Ciccone D.N., Taverna S.D., Allis C.D., and Oettinger M.A. Antigen receptor loci poised for V(D)J rearrangement are broadly associated with BRG1 and flanked by peaks of histone H3 dimethylated at lysine 4. Proc Natl Acad Sci U S A 100 (2003) 11577-11582
40. Kwon J., Morshead K.B., Guyon J.R., Kingston R.E., and Oettinger M.A. Histone acetylation and hSWI/SNF remodeling act in concert to stimulate V(D)J cleavage of nucleosomal DNA. Mol Cell 6 (2000) 1037-1048
41. Patenge N., Elkin S.K., and Oettinger M.A. ATP-dependent remodeling by SWI/SNF and ISWI proteins stimulates V(D)J cleavage of 5 S arrays. J Biol Chem 279 (2004) 35360-35367
42. Golding A., Chandler S., Ballestar E., Wolffe A.P., and Schlissel M.S. Nucleosome structure completely inhibits in vitro cleavage by the V(D)J recombinase. Embo J 18 (1999) 3712-3723
43. Spicuglia S., Kumar S., Yeh J.H., Vachez E., Chasson L., Gorbatch S., et al. Promoter activation by enhancer-dependent and -independent loading of activator and coactivator complexes. Mol Cell 10 (2002) 1479-1487
44. Pattenden S.G., Klose R., Karaskov E., and Bremner R. Interferon-gamma-induced chromatin remodeling at the CIITA locus is BRG1 dependent. Embo J 21 (2002) 1978-1986
45. Goodbourn S., Didcock L., and Randall R.E. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81 (2000) 2341-2364
46. Mudhasani R., and Fontes J.D. The class II transactivator requires brahma-related gene 1 to activate transcription of major histocompatibility complex class II genes. Mol Cell Biol 22 (2002) 5019-5026